There are no adequate data from the use of Lixisenatide in pregnant women. Studies in animals have shown reproductive toxicity. The potential risk for humans is unknown. Lixisenatide should not be used during pregnancy. The use of insulin is recommended instead. If a patient wishes to become pregnant, or pregnancy occurs, treatment with Lixisenatide should be discontinued.